Welcome to our dedicated page for Profusa SEC filings (Ticker: NVACW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Profusa, Inc. filings document the digital health company’s securities registration activity, material events, and public-company status. Its S-1 and S-1/A registration statements describe offering-related disclosures, security structure, capital structure, risk factors, and the company’s status as an emerging growth company and smaller reporting company.
Profusa’s 8-K reports cover Nasdaq listing compliance matters, material agreements, shareholder voting matters, and other capital-structure or security-structure disclosures. These filings provide the formal record for corporate events affecting the company and its warrant security.
Profusa, Inc. disclosed that Nasdaq notified the company it no longer meets the minimum bid price requirement for listing on the Nasdaq Global Market. The notice reports the closing bid price of the company's common stock was below the $1.00 per share threshold during the measurement period from July 29, 2025 to September 10, 2025.
The filing identifies the specific Nasdaq Listing Rule (5450(a)(1)) related to the minimum bid price standard and is presented as a material notice in an 8-K. No other operational, financial, or remedial actions were included in the provided text.